Publications by authors named "Malcolm D Mason"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

297

Total Likes

2

Extended Reach

34,854

Social Features

3
P
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Athene Lane, Chris Metcalfe, Grace J Young, Tim J Peters, Jane Blazeby, Kerry N L Avery, Daniel Dedman, Liz Down, Malcolm D Mason, David E Neal

BJU Int· December 2016

Videos about Article: user

1 2 2

View All Article and Social Media Activity
M
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Silke Gillessen, Laura Murphy, Nicholas D James, Ashwin Sachdeva, Omar El-Taji, Malcolm D Mason

Lancet Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
Richard M Martin, Emma L Turner, Grace J Young, Chris Metcalfe, Eleanor I Walsh, Malcolm D Mason

JAMA· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells.
Wen G Jiang, Lin Ye, Fiona Ruge, Sioned Owen, Tracey Martin, Malcolm D Mason

J Transl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
Giancarlo Marra, Geert J L H van Leenders, Fabio Zattoni, Claudia Kesch, Pawel Rajwa, Malcolm D Mason

Eur Urol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Gerhardt Attard, Laura Murphy, Noel W Clarke, Ashwin Sachdeva, Craig Jones, Malcolm D Mason

Lancet Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
Janet Athene Lane, Jenny L Donovan, Grace J Young, Michael Davis, Eleanor I Walsh, Malcolm D Mason

BJU Int· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Nicholas D James, Noel W Clarke, Adrian Cook, Adnan Ali, Alex P Hoyle, Malcolm D Mason

Int J Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.
Nicholas D James, Fiona C Ingleby, Noel W Clarke, Claire L Amos, Gerhardt Attard, Malcolm D Mason

JNCI Cancer Spectr· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
Chris C Parker, Nicholas D James, Christopher D Brawley, Noel W Clarke, Adnan Ali, Malcolm D Mason

PLoS Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.
Peter-Paul M Willemse, Niall F Davis, Nikolaos Grivas, Fabio Zattoni, Michael Lardas, Malcolm D Mason

Eur Urol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern Imaging in Prostate Cancer: Do We Treat Patients, or Their Scans?
Malcolm D Mason, Theodorus H van der Kwast, Nicolas Mottet, Daniela E Oprea-Lager, Olivier Rouvière

Eur Urol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Gerhardt Attard, Laura Murphy, Noel W Clarke, William Cross, Robert J Jones, Malcolm D Mason

Lancet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.
Anthony S Bates, Jennifer Ayers, Nikolaos Kostakopoulos, Thomas Lumsden, Ivo G Schoots, Malcolm D Mason

Eur Urol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Adnan Ali, Alex Hoyle, Áine M Haran, Christopher D Brawley, Adrian Cook, Malcolm D Mason

JAMA Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
Philip Cornford, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus G Cumberbatch, Malcolm D Mason

Eur Urol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Nicolas Mottet, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus G Cumberbatch, Malcolm D Mason

Eur Urol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial.
Clare Gilson, Fiona Ingleby, Duncan C Gilbert, Marina A Parry, Nafisah B Atako, Malcolm D Mason

JCO Precis Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE's "M1|RT Comparison".
Adnan Ali, Alex P Hoyle, Christopher C Parker, Christopher D Brawley, Adrian Cook, Malcolm D Mason

Eur Urol Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
Lisa Moris, Marcus G Cumberbatch, Thomas Van den Broeck, Giorgio Gandaglia, Nicola Fossati, Malcolm D Mason

Eur Urol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.
Alex P Hoyle, Adnan Ali, Nicholas D James, Adrian Cook, Christopher C Parker, Malcolm D Mason

Eur Urol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
Thomas B L Lam, Steven MacLennan, Peter-Paul M Willemse, Malcolm D Mason, Karin Plass

Eur Urol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study.
David W Donnelly, Linda C Vis, Therese Kearney, Linda Sharp, Damien Bennett, Malcolm D Mason

BMC Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination.
Andrew J Sanders, Sioned Owen, Liam D Morgan, Fiona Ruge, Ross J Collins, Malcolm D Mason

Oncotarget· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom.
David W Donnelly, Anna Gavin, Amy Downing, Luke Hounsome, Therese Kearney, Malcolm D Mason

Eur Urol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Beth S Woods, Eleftherios Sideris, Matthew R Sydes, Melissa R Gannon, Mahesh K B Parmar, Malcolm D Mason

Eur Urol Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis